A clinical investigation assessed circulating FGF21 levels in 2066 hospitalized patients with DM, revealing that individuals in the low urinary glucose excretion group exhibited higher body mass index (BMI) and serum FGF21 levels. The gene discussed is FGF21; the disease is diabetes mellitus.